# Athletigen Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/athletigen-technologies

- Industry: Software
- Headquarters: Halifax, Canada
- Website: www.athletigen.com
- Total disclosed funding: $1.6M
- Latest round: Seed (Jan 4, 2016)
- Investors on record: 1

## About

Athletigen Technologies Inc. specializes in biotechnology, providing personalized health and wellness solutions through advanced genetic testing services that empower consumers with insights into their health, fitness, and nutrition.Founded in 2014 in Halifax, Canada, Athletigen Technologies Inc. is focused on delivering genetic insights for health and wellness. The company is led by CEO Jeremy Koenig. In January 2016, Athletigen raised USD 1.55 mn in Seed funding from Exponential Partners, marking its only known deal to date.Athletigen operates as a biotechnology company, focusing on personalized health and wellness solutions through genetic insights. Their core offerings include advanced genetic testing services that provide consumers with actionable information regarding their health, fitness, and nutrition. By leveraging genetic data, the company’s products aim to enhance athletic performance and overall wellness, targeting athletes, fitness enthusiasts, and health-conscious individuals. These services address specific use cases such as optimizing training regimens, informing dietary choices, and identifying health predispositions. Athletigen markets its offerings to a diverse clientele across North America, Europe, and select regions in Asia, facilitating a global presence in the personalized health sector.Athletigen's revenue model is based on direct-to-consumer transactions and subscription services for their genetic testing products. Customers engage through a digital platform to order genetic testing kits, submit samples, and receive comprehensive reports on their genetic predispositions and personalized recommendations. The transaction structure includes one-time purchases for testing kits and subscription options for ongoing access to updated genetic insights. Athletigen's flagship products, which consist of various genetic testing kits, are priced for both casual consumers and serious athletes, enabling a broad range of purchasing scenarios, thus generating steady cash flow while expanding the customer base in the health and wellness industry.Athletigen Technologies Inc. plans to leverage its recent Seed funding of USD 1.55 mn raised in January 2016 to support the development of new genetic testing products and expand its market reach. The company aims to launch additional offerings targeting various health applications within the next 12-18 months. Furthermore, Athletigen is focusing on expanding into new geographic markets, specifically targeting additional regions in Asia and Europe by 2025, enhancing its global footprint in the personalized health sector.

## Funding rounds

- Seed, Jan 4, 2016, $1.6M — Exponential Partners

## Investors

- Exponential Partners (https://capitalatlas.ai/funds/exponential-partners) — Seed